-
Bachter D.
Operative Therapie maligner Melanome der Haut.
Klinische Onkologie 2000;1:61-67.
-
Balch CM et al.
Efficacy of 2 cm surgical margins for intermediate thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.
Ann Surg 1993;218:262-267.
-
Bong JL, Herd RM, Hunter JAA.
Incisional biopsy and melanoma prognosis.
J Am Acad Dermatol 2002;46:690-694.
-
Breuninger H et al.
Patterns of local horizontal spread of melanomas: consequences for surgery and histopathologic investigation.
Am J Surg Pathol 1999;23:1493-1498.
-
Breuninger H, Kettelhack C.
Therapie des primären und metastasierten Melanoms.
Onkologe 2001;7:36-43.
-
Büchels HK, Vogt H, Bachter D.
Szintillationssondengesteurte Sentinel-Lymphadenektomie beim malignen Melanom.
Chirurg 1997;68:45-50.
-
Cascinelli N et al.
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial.
Lancet 1998;351:793-796.
-
Cochran AJ et al.
The Augsburg Consensus. Technique of lymphatic mapping, sentinel lymphadenektomy, and completion lymphadenectomy in cutaneous malignancies.
Cancer 2000;15:236-241.
-
Dummer R et al.
Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
Dermatology 2001;203:75-80.
-
Farshad A et al.
A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays.
Br J Dermatol 2002;146:1042-1046.
-
Gershenwald JE et al.
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
J Clin Oncol 1999;17:976-982.
-
Hauschild A et al.
Sicherheitsabstände bei der Exzision des primären malignen Melanoms. Diskussionsvorschläge aufgrund von Ergebnissen aus kontrollierten klinischen Studien.
Hautarzt 2001;52:1003-1010.
-
Heaton KM et al.
Surgical margins and prognostic factors in patients with thick (> 4 mm) primary melanoma.
Ann Surg Oncol 1998;5:322-328.
-
Heidenreich P et al.
Das Konzept des Wächterlymphknotens: Stand und medizinische Bedeutung.
Dtsch Ärztebl 2001;98:534-544.
-
Kaufmann R.
Surgical management of primary melanoma.
Clin Exp Dermatol 2000;25:476-481.
-
Kaufmann R, Tilgen W, Garbe C.
Diagnostische und therapeutische Standards in der Dermatologischen Onkologie.
Hautarzt 1998;49:30-38.
-
Konrad H, Wollina U.
Sentinel-Lymph-Node-Biopsie beim malignen Melanom.
Akt Dermatol 2005;31:148-150.
-
Lienard D et al.
Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.
Melanoma Res 1999;9:491-502.
-
McMasters KM et al.
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement.
J Clin Oncol 2001;19:2851-2855.
-
Morton DL et al.
Technical details of lymphatic mapping for early stage melanoma.
Arch Surg 1992;127:392-399.
-
O'Rourke MG, Altmann CR.
Melanoma recurrence after excision. Is a wide margin justified?
Ann Surg 1993;217:2-5.
-
Ringborg U et al.
Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.
Cancer 1996;77:1809-1814.
-
Roberts DDLL et al.
U. K. guidelines for the management of cutaneous melanoma.
Br J Dermatol 2002;146:7-17.
-
Sober AJ et al.
Guidelines of care for primary cutaneous melanoma.
J Am Acad Dermatol 2001;45:579-586.
-
Starz H et al.
A Micromorphometry-Based Concept for Routine Classification of Sentinel Lymph Node Metastases and IST Clinical Relevance for Patients with Melanoma.
Cancer 2001;91:2110-2121.
-
Thoma JM, Patocskai EJ.
The argument against sentinel node biopsy for malignant melanoma.
BMJ 2000;321:3-4.
-
Veronesi U, Cascinelli N.
Narrow excision (1 cm margin). A safe procedure for thin cutaneous melanoma.
Arch Surg 1991;126:438-441.
Bildatlas Hämatologie
Druckversion
ISSN: 2193-6021
Zum Seitenanfang